Javier López-Belmonte Encina
Director of Finance/CFO at LABORATORIOS FARMACEUTICOS ROVI, S.A.
Profile
Presently, Javier López-Belmonte Encina holds the position of Chief Executive Officer & Secretary at Norbepa Inversiones, S.l., Vice Chairman & Chief Financial Officer at Laboratorios Farmaceúticos Rovi SA, Director & Deputy Secretary at Alentia Biotech SLU (a subsidiary of Laboratorios Farmaceúticos Rovi SA) and Secretary & Director at Enervit Nutrition SL. He is also Director & Deputy Secretary at Alentia Biotech SLU and Member-Social Council at Universidad Autónoma de Madrid and on the board of 6 other companies. In the past Javier López-Belmonte Encina occupied the position of Analyst at Argentaria SA. He received an undergraduate degree from Colegio Universitario de Estudios Financieros and an MBA from Brown University.
Javier López-Belmonte Encina active positions
Companies | Position | Start |
---|---|---|
LABORATORIOS FARMACEUTICOS ROVI, S.A. | Director of Finance/CFO | 01/01/2001 |
Inversiones Clidia SL
Inversiones Clidia SL Pharmaceuticals: MajorHealth Technology Inversiones Clidia SL is a holding Spanish company with interests in the pharmaceutical sector. The private company is based in Madrid, Spain. | Director/Board Member | - |
Norbepa Inversiones, S.l. | Chief Executive Officer | - |
Lobel Y Losa Development SL | Director/Board Member | - |
Inversiones Borbollon SL | Director/Board Member | - |
Alentia Biotech SLU | Director/Board Member | - |
Norbel Inversiones SL
Norbel Inversiones SL Pharmaceuticals: MajorHealth Technology Norbel Inversiones SL is based in Madrid, Spain and has subsidiaries in Germany, Spain, and France. The Spanish company specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company's diverse product portfolio includes diagnostic imaging products and other hospital supplies. Norbel Inversiones SL is a pharmaceutical company founded in 2015. | Director/Board Member | - |
Confederación Empresarial de Madrid | Corporate Officer/Principal | - |
Avalmadrid S.G.R | Director/Board Member | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Former positions of Javier López-Belmonte Encina
Companies | Position | End |
---|---|---|
░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Javier López-Belmonte Encina
Brown University | Masters Business Admin |
Colegio Universitario de Estudios Financieros | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LABORATORIOS FARMACEUTICOS ROVI, S.A. | Health Technology |
Private companies | 11 |
---|---|
Argentaria SA | Finance |
Avalmadrid S.G.R | |
Inversiones Clidia SL
Inversiones Clidia SL Pharmaceuticals: MajorHealth Technology Inversiones Clidia SL is a holding Spanish company with interests in the pharmaceutical sector. The private company is based in Madrid, Spain. | Health Technology |
Confederación Empresarial de Madrid | |
Norbepa Inversiones, S.l. | |
Lobel Y Losa Development SL | |
Inversiones Borbollon SL | |
Alentia Biotech SLU | |
Norbel Inversiones SL
Norbel Inversiones SL Pharmaceuticals: MajorHealth Technology Norbel Inversiones SL is based in Madrid, Spain and has subsidiaries in Germany, Spain, and France. The Spanish company specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company's diverse product portfolio includes diagnostic imaging products and other hospital supplies. Norbel Inversiones SL is a pharmaceutical company founded in 2015. | Health Technology |
Enervit Nutrition SL
Enervit Nutrition SL Food DistributorsDistribution Services Enervit Nutrition SL is a Spanish company that distributes Enervit products. The private company is based in Madrid, Spain. The CEO of the company is Iván López-Belmonte Encina. | Distribution Services |
Fundación Universidad Autonoma De Madrid |
- Stock Market
- Insiders
- Javier López-Belmonte Encina